IPO
-
-
-
-
-
-
-
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
-
-
-
-
-
-
-
60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
-
-
-
-
-
-
-
WallachBeth Capital Announce Pricing Of 60 Degrees Pharmaceuticals IPO At $5.30 Per Unit
-
122,357 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

